Evidence map›Paper›PMID 28710492›Full record

ArticleScientific reports2017

NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin.

Talita D Melo-Hanchuk, Priscila Ferreira Slepicka, Gabriela Vaz Meirelles, Fernanda Luisa Basei, Diogo Ventura Lovato, Daniela Campos Granato, Bianca Alves Pauletti, Romenia Ramos Domingues, Adriana Franco Paes Leme, Alessandra Luiza Pelegrini and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Classifying protein kinase conformations with machine learning.Protein science : a publication of the Protein Society · 2024
    Article
  11. Review
  12. Article
  13. Targeting Prostate Cancer, the 'Tousled Way'.International journal of molecular sciences · 2023
    Review
  14. Article
  15. In Vitro Transcriptional Response ofInternational journal of molecular sciences · 2023
    Article
  16. Review
  17. In Mitosis You Are Not: The NIMA Family of Kinases inInternational journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Talita D Melo-HanchukInstituto de Biologia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
Priscila Ferreira SlepickaLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo, Brazil.
Gabriela Vaz MeirellesInstituto de Biologia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
Fernanda Luisa BaseiInstituto de Biologia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
Diogo Ventura LovatoLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo, Brazil.ORCID 0000-0001-6631-238X
Daniela Campos GranatoLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo, Brazil.
Bianca Alves PaulettiLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo, Brazil.
Romenia Ramos DominguesLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo, Brazil.
Adriana Franco Paes LemeLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas, São Paulo, Brazil.
Alessandra Luiza PelegriniCenter of Biotechnology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Guido LenzCenter of Biotechnology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Stefan KnappStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Jonathan M ElkinsStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-2858-8929
Jörg KobargInstituto de Biologia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil. jorgkoba@unicamp.br.
Laboratório Nacional de Ciência e Tecnologia do Bioetanol · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal do Rio Grande do Sul · BRGoethe University Frankfurt · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

NEK family kinases are serine/threonine kinases that have been functionally implicated in the regulation of the disjunction of the centrosome, the assembly of the mitotic spindle, the function of the primary cilium and the DNA damage response. NEK1 shows pleiotropic functions and has been found to be mutated in cancer cells, ciliopathies such as the polycystic kidney disease, as well as in the genetic diseases short-rib thoracic dysplasia, Mohr-syndrome and amyotrophic lateral sclerosis. NEK1 is essential for the ionizing radiation DNA damage response and priming of the ATR kinase and of Rad54 through phosphorylation. Here we report on the structure of the kinase domain of human NEK1 in its apo- and ATP-mimetic inhibitor bound forms. The inhibitor bound structure may allow the design of NEK specific chemo-sensitizing agents to act in conjunction with chemo- or radiation therapy of cancer cells. Furthermore, we characterized the dynamic protein interactome of NEK1 after DNA damage challenge with cisplatin. Our data suggest that NEK1 and its interaction partners trigger the DNA damage pathways responsible for correcting DNA crosslinks.

Indexed as

DNA RepairAntineoplastic AgentsBinding SitesCisplatinCloning, MolecularCrystallography, X-RayDNA DamageEscherichia coliGene ExpressionGenetic VectorsHEK293 CellsHumansKineticsModels, MolecularNIMA-Related Kinase 1PhosphorylationAntineoplastic AgentsCisplatinNEK1 protein, humanNIMA-Related Kinase 1Protein Kinase InhibitorsRecombinant Proteins

Identifiers

PMID28710492
PMCPMC5511132
OpenAlexW2734507137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.